8
Shared Docs
8
Same-Page
8 / 8
Mentions
while since I was in touch! I emailed Jeffrey and Rich last night but wasn't sure that they still use t
ou still use this email? Since working for your foundation, I continued to publish as a journalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapies
ff To: Jefffrey Epstein <[email protected]>, Rich Kahn < Subject: Date: Thu, 17 Jan 2019 17:19:49
you still use this email? Since working for your foundation, I continued to publish as a joumalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapies
while since I was in touch! I emailed Jeffrey and Rich last night but wasn't sure that they still use t
1_01089030 EFTA02275302 Since working for your foundation, I continued to publish as a journalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapie
while since I was in touch! I emailed Jeffrey and Rich last night but wasn't sure that they still use t
ou still use this email? Since working for your foundation, I continued to publish as a journalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapie
To: Jefffrey Epstein[[email protected]]; Rich Kahn From: Lesley Groff Sent: Thur 1/17/2019
ou still use this email? Since working for your foundation, I continued to publish as a journalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapie
I could provide in exchange for that. I am &ling Rich because I'm not sure if you still use this email?
you still use this email? Since working for your foundation, I continued to publish as a journalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age-driven or degenerative diseases. Most of the therapie
could provide in exchange for that. I am cc'ing Rich because I'm not sure if you still use this email?
ou still use this email? Since working for your foundation, I continued to publish as a journalist writing mostly about genetic vectors (Newsweek, Techonomy etc). I then set up an LLC that provides business development for labs that have reversed age- driven or degenerative diseases. Most of the therapie
January 17, 2019 5:20 PM To: Jefffrey Epstein; Rich Kahn Subject: requested I forward you the below
you still use this email? Since working for your foundation, I =ontinued to publish as a journalist writing mostly about genetic =ectors (Newsweek, Techonomy etc). I then set up an =LC that provides business development for labs that have reversed =ge- driven or degenerative diseases. Most of the therapies
Entities connected to both Marc Rich and Techonomy

Jeffrey Epstein
PERSON
Richard Kahn
PERSON
Lesley Groff
PERSONLexington
LOCATIONthe National Institute of Medicine
ORGANIZATIONBioHebe LLC
LOCATION